Fig. 1From: Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: the EPIKART Study, a Pilot Prospective Comparative Randomized Double Blind TrialIndividual change of Coll2-1 level in serum of patient receiving placebo (a) or treated with Kartilage Cross (b)Back to article page